MYLAN EPIPEN SHORTAGE MAY LAST FOR MONTHS
Mylan, a major provider of insect bite-and food allergy-countering Epi-Pens, is facing a temporary shortage due to manufacturing delays, according to the Food and Drug Administration. The shortage is only in some markets and is likely to last a few months as Mylan partner Pfizer ramps up production to meet demand.